Los puntos clave no están disponibles para este artículo en este momento.
Among patients diagnosed with cancer in California and Georgia between 2013 and 2019, only 6.8% underwent germline genetic testing. Compared with non-Hispanic White patients, rates of testing were lower among Asian, Black, and Hispanic patients.
Kurian et al. (Mon,) studied this question.